Amin S Herati1, Robert Miles Moldwin. 1. Smith Institute for Urology, Hofstra North Shore LIJ School of Medicine, Lake Success, New York, NY, USA.
Abstract
PURPOSE: Standard medical therapy for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) including such agents as nonsteriodal anti-inflammatories, alpha-blockers, antimicrobial therapy, and 5a-reductase inhibitors has not been uniformly effective. The purpose of this review is to focus on the role of alternative therapies available for the management of CP/CPPS. METHODS: We performed a systematic review of the literature for articles published in PubMed up to 2012 pertaining to commonly employed alternative therapies. RESULTS: The evidence for alternative therapies such as diet and lifestyle modifications, phytotherapy, acupuncture, myofascial physical therapy, and stress management/cognitive behavioral therapy is reviewed. CONCLUSION: CP/CPPS often requires a multimodal approach and alternative therapies should be considered as adjuncts in the treatment of refractory CP/CPPS patients.
PURPOSE: Standard medical therapy for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) including such agents as nonsteriodal anti-inflammatories, alpha-blockers, antimicrobial therapy, and 5a-reductase inhibitors has not been uniformly effective. The purpose of this review is to focus on the role of alternative therapies available for the management of CP/CPPS. METHODS: We performed a systematic review of the literature for articles published in PubMed up to 2012 pertaining to commonly employed alternative therapies. RESULTS: The evidence for alternative therapies such as diet and lifestyle modifications, phytotherapy, acupuncture, myofascial physical therapy, and stress management/cognitive behavioral therapy is reviewed. CONCLUSION: CP/CPPS often requires a multimodal approach and alternative therapies should be considered as adjuncts in the treatment of refractory CP/CPPSpatients.
Authors: Tommaso Cai; Florian M E Wagenlehner; Lorenzo Giuseppe Luciani; Daniele Tiscione; Gianni Malossini; Paolo Verze; Vincenzo Mirone; Riccardo Bartoletti Journal: Exp Ther Med Date: 2014-07-24 Impact factor: 2.447
Authors: Tommaso Cai; Paolo Verze; Roberto La Rocca; Alessandro Palmieri; Daniele Tiscione; Lorenzo Giuseppe Luciani; Sandra Mazzoli; Vincenzo Mirone; Gianni Malossini Journal: World J Mens Health Date: 2017-04-30 Impact factor: 5.400